Search research articles
Contact Us
Filters
Showing results (101-110 of 208) with videos related to
Page
of 21
Sort By:
The Prostate
|
May 4, 2011
Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion
Meng Sun, Chengfei Liu, Nagalakshmi Nadiminty, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
December 31, 2016
Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?
Thenappan Chandrasekar, Neil Pugashetti, Blythe Durbin-Johnson, et al.
World Journal of Urology
|
June 17, 2016
Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry
Stanley A Yap, Lindsay M Yuh, Christopher P Evans, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
February 1, 2018
A contemporary population-based study of testicular sex cord stromal tumours: Presentation, treatment patterns, and predictors of outcome
Lindsay M Yuh, Primo N Lara, Rebecca M Wagenaar, et al.
Urology Practice
|
June 14, 2023
The Promise and Disappointment of Neoadjuvant Chemotherapy and Transurethral Resection for Muscle Invasive Bladder Cancer: Updated Results and Long-Term Followup
Stanley A Yap, Neil Pugashetti, Thenappan Chandrasekar, et al.
Oncogene
|
February 10, 2004
Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK
Li-Fen Lee, Maggie C Louie, Sonal J Desai, et al.
The American Journal of Pathology
|
June 25, 2013
Lin28 promotes growth of prostate cancer cells and activates the androgen receptor
Ramakumar Tummala, Nagalakshmi Nadiminty, Wei Lou, et al.
Cancer Research
|
February 5, 2015
Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer
Chengfei Liu, Wei Lou, Yezi Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2020
Newly Diagnosed High-Risk Prostate Cancer in an Era of Rapidly Evolving New Imaging: How Do We Treat?
Maha Hussain, Daniel Lin, Fred Saad, et al.
Cancers
|
April 30, 2021
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling
Xiong Zhang, Zenghong Huang, Junjian Wang, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 208) with videos related to
Sort By:
Page
of 21
The Prostate
|
May 4, 2011
Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion
Meng Sun, Chengfei Liu, Nagalakshmi Nadiminty, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
December 31, 2016
Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?
Thenappan Chandrasekar, Neil Pugashetti, Blythe Durbin-Johnson, et al.
World Journal of Urology
|
June 17, 2016
Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry
Stanley A Yap, Lindsay M Yuh, Christopher P Evans, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
February 1, 2018
A contemporary population-based study of testicular sex cord stromal tumours: Presentation, treatment patterns, and predictors of outcome
Lindsay M Yuh, Primo N Lara, Rebecca M Wagenaar, et al.
Urology Practice
|
June 14, 2023
The Promise and Disappointment of Neoadjuvant Chemotherapy and Transurethral Resection for Muscle Invasive Bladder Cancer: Updated Results and Long-Term Followup
Stanley A Yap, Neil Pugashetti, Thenappan Chandrasekar, et al.
Oncogene
|
February 10, 2004
Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK
Li-Fen Lee, Maggie C Louie, Sonal J Desai, et al.
The American Journal of Pathology
|
June 25, 2013
Lin28 promotes growth of prostate cancer cells and activates the androgen receptor
Ramakumar Tummala, Nagalakshmi Nadiminty, Wei Lou, et al.
Cancer Research
|
February 5, 2015
Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer
Chengfei Liu, Wei Lou, Yezi Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2020
Newly Diagnosed High-Risk Prostate Cancer in an Era of Rapidly Evolving New Imaging: How Do We Treat?
Maha Hussain, Daniel Lin, Fred Saad, et al.
Cancers
|
April 30, 2021
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling
Xiong Zhang, Zenghong Huang, Junjian Wang, et al.
Page
of 21